2Akosman C, Selcuk NA, Ordu C, et al. Unieentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment [J]. Cancer Imaging, 2011,11 ( 1 ) : 52-55.
2Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care [J]. Sr J Haematol, 2005, 129( 1 ) :3-17.
3Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, muhicentric Castleman's disease, and primary effusion lymphoma [J]. Proc Natl Acad Sci USA, 1999, 96(8) :4546- 4551.
4Parravicini C, Corbellino M, Paulli M, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease [J]. Am J Pathol, 1997, 151 (6): 1517-1522.
5Oksenhendler E, Careelain G, Aoki Y, et al. High levels of HHV8 viral load, human interleukin-6, interleukin-10, and C reactive protein are correlate with exacerbation of multicentric Castleman disease in HIV-infected patients [ J ]. Blood, 2000, 96 (6) :2069-2073.
6Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [J]. Blood, 1995, 86(4) :1276- 1280.
7Yamasaki S, Iino T, Nakamura M, et al. Detection of human herpesvirus-8 in peripheral blood mononuclear cells from adult Japanese patients with uhicentric Castleman's disease [J]. Br J Haematol, 2003, 120(3) :471-477.
8Tedeschi R, Marus A, Bidoli E, et al. Human herpesvirus 8 DNA quantification in matched plasma and PBMCs samples of patients with HHV8-related lymphoproliferative diseases [J]. J Clin Virol, 2008, 43(3) :255-259.
9Kreft A, Weber A, Springer E, et al. Bone marrow findings in multicentric Castleman disease in HIV-negative patients [J]. Am J Surg Pathol, 2007, 31(3) :398-402.
10Brandt S, Bodine D, Dunbar C, et al. Dysregulated interleukin 6 expression produces a syndrome resembling Casfleman's disease in mice [J]. J Clin Invest, 1990, 86 (2) :592-599.
